Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Phase I Study Investigating the Safety of Stereotactic Body Radiotherapy (SBRT) With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Nivolumab (and other agents affecting the anti-programmed death-1 \[anti-PD-1\] pathway) have demonstrated anti-tumor activity in multiple tumor types. Combina…
MelanomaUnresectable Solid TumorsNeoplasms+7 more
Estimated
~$10 – $7,500
Yana NajjarNCT04572451
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
ArthritisPolymyalgia RheumaticaImmune Checkpoint Inhibitors
Estimated
~$10 – $750
M.D. Anderson Cancer CenterNCT06647134